Rapid Activation of Glycogen Phosphorylase by the Endoplasmic Reticulum Unfolded Protein Response

Arvind Gill, Ningguo Gao, Mark A. Lehrman

Journal of Biological Chemistry · 2002 · 14 citations · 15 references

DOIFull text

Open access

Concepts

Abstract

Endoplasmic reticulum (ER) stress is associated with misfolding of ER proteins and triggers the unfolded protein response (UPR). The UPR, in turn, helps restore normal ER function. Since fastidious N-linked glycosylation is critical for folding of most ER proteins, this study examined whether metabolic interconversions of precursors used for glycan assembly were controlled by the UPR. Thus, eight enzymes and factors with key roles in hexose phosphate metabolism were assayed in cytoplasmic extracts from primary dermal fibroblasts treated with UPR inducers. Stimulation of only one activity by the UPR was detected, AMP-independent glycogen phosphorylase (GP). GP activation required only 20 min of ER stress, with concurrent decreases in cellular glycogen and elevations of its metabolites Glc-1-P and Glc-6-P. Addition of phosphatase inhibitors to enzyme extracts from unstressed cells mimicked the effect of ER stress on GP activity, suggesting that phosphorylation of GP or a regulatory factor was involved. These data show that the UPR can modulate hexose metabolism in a manner beneficial for protein glycosylation. Since activation of GP appears to occur by a rapid post-translational process, it may be part of a general strategy of ER damage control, preceding the well-known transcription-dependent processes of the UPR that are manifested hours after the occurrence of ER stress. Endoplasmic reticulum (ER) stress is associated with misfolding of ER proteins and triggers the unfolded protein response (UPR). The UPR, in turn, helps restore normal ER function. Since fastidious N-linked glycosylation is critical for folding of most ER proteins, this study examined whether metabolic interconversions of precursors used for glycan assembly were controlled by the UPR. Thus, eight enzymes and factors with key roles in hexose phosphate metabolism were assayed in cytoplasmic extracts from primary dermal fibroblasts treated with UPR inducers. Stimulation of only one activity by the UPR was detected, AMP-independent glycogen phosphorylase (GP). GP activation required only 20 min of ER stress, with concurrent decreases in cellular glycogen and elevations of its metabolites Glc-1-P and Glc-6-P. Addition of phosphatase inhibitors to enzyme extracts from unstressed cells mimicked the effect of ER stress on GP activity, suggesting that phosphorylation of GP or a regulatory factor was involved. These data show that the UPR can modulate hexose metabolism in a manner beneficial for protein glycosylation. Since activation of GP appears to occur by a rapid post-translational process, it may be part of a general strategy of ER damage control, preceding the well-known transcription-dependent processes of the UPR that are manifested hours after the occurrence of ER stress. Endoplasmic reticulum (ER) 1The abbreviations used are: ER, endoplasmic reticulum; AMAC, 2-aminoacridone; AZC, l-azetidine-2-carboxylic acid; CDG, congenital disorder of glycosylation; CSN, castanospermine; DTT, dithiothreitol; eIF, eukaryotic initiation factor; FACE, fluorophore-assisted carbohydrate electrophoresis; GP, glycogen phosphorylase; LLO, lipid-linked oligosaccharide; PERK, PKR-like ER kinase; SLO, streptolysin-O; TN, tunicamycin; UPR, unfolded protein response. stress initiates signals that emerge from the ER lumen, and activate cytoplasmic and/or nuclear responses, which in turn alter ER function. The general paradigm of ER stress signaling is termed the unfolded protein response (UPR) (1Patil C. Walter P. Curr. Opin. Cell Biol. 2001; 13: 349-356Google Scholar, 2Mori K. Cell. 2000; 101: 451-454Google Scholar, 3Ma J. Hendershot L.M. Cell. 2001; 107: 827-830Google Scholar), which can be triggered by agents that cause misfolded proteins to accumulate within the ER lumen, such as dithiothreitol (DTT), tunicamycin (TN), thapsigargin, castanospermine (CSN), and azetidine-2-carboxylic acid (AZC) (4Shang J. Koerner C. Freeze H.H. Lehrman M.A. Glycobiology. 2002; 12: 307-317Google Scholar). Typically, ER stress activates the stress sensors Ire1p and ATF6 (3Ma J. Hendershot L.M. Cell. 2001; 107: 827-830Google Scholar) to cause transcription of genes encoding chaperones, folding enzymes, and other proteins that enhance ER function. Appearance of the respective gene products occurs several hours after initiation of ER stress. For such ER proteins, there is no evidence that regulation by the UPR involves post-translational import or activation. Additionally, ER stress can temporarily inhibit cellular protein synthesis, lessening the load of misfolded protein entering the lumenal space. This occurs within 10–20 min of the application of ER stress by rapid post-translational phosphorylation of eIF2α by the PKR-like ER kinase or PERK (5Harding H.P. Zhang Y. Ron D. Nature. 1999; 397: 271-274Google Scholar). Translation arrest is reversible (for example, lasting 2 h in fibroblasts, Ref. 4Shang J. Koerner C. Freeze H.H. Lehrman M.A. Glycobiology. 2002; 12: 307-317Google Scholar), allowing the subsequent translation of mRNAs encoded by UPR-responsive genes. Previous studies from this laboratory with primary dermal fibroblasts identified another rapid effect of the UPR, involvingN-linked glycosylation of ER proteins (4Shang J. Koerner C. Freeze H.H. Lehrman M.A. Glycobiology. 2002; 12: 307-317Google Scholar, 6Doerrler W.T. Lehrman M.A. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 13050-13055Google Scholar). ER quality control is highly dependent upon covalent attachment of the oligosaccharide Glc3Man9GlcNAc2 to specific asparaginyl residues of nascent ER proteins. This requires the synthesis of a lipid-linked oligosaccharide (LLO), Glc3Man9GlcNAc2-P-P-dolichol. TN is a specific inhibitor of the synthesis of this LLO and, as a result, its application with cells causes ER protein misfolding and ER stress. Conditions that cause accumulation of premature LLO intermediates also result in ER stress (7Lehrman M.A. J. Biol. Chem. 2001; 276: 8623-8626Google Scholar). However, it was found that the UPR can compensate by promoting extension of such premature LLOs to Glc3Man9GlcNAc2-P-P-dolichol (6Doerrler W.T. Lehrman M.A. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 13050-13055Google Scholar). Of particular interest is DTT-induced stress, which stimulates LLO synthesis within 20 min, and is attenuated by adaptation of cells to ER stress (4Shang J. Koerner C. Freeze H.H. Lehrman M.A. Glycobiology. 2002; 12: 307-317Google Scholar). This suggests a form of stress relief in which one or more components of the pre-existing pathway for generation of Glc3Man9GlcNAc2-P-P-dolichol is activated post-translationally, rather than being synthesized de novo. No evidence was obtained for UPR activation of hexose transport or transferases involved in synthesis of Glc3Man9GlcNAc2-P-P-dolichol (6Doerrler W.T. Lehrman M.A. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 13050-13055Google Scholar). Since multiple undermannosylated intermediates (Man2–5GlcNAc2-P-P-dolichol) were all extended by the UPR, it is feasible that the UPR acts by increasing synthesis of one or more precursors of the mannosyl residues. In this study we present evidence that AMP-independent glycogen phosphorylase (GP) can mediate enhanced LLO extension by the UPR. Activation of GP is rapid, and may be part of a general program of ER damage control that precedes transcriptional events regulated by the UPR. Human dermal fibroblasts, obtained from various sources (see below, Table II), were cultured and subjected to ER stress with DTT, TN, CSN, or AZC as described (6Doerrler W.T. Lehrman M.A. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 13050-13055Google Scholar). Cells were cultured continuously in medium containing 5 mm glucose in all experiments presented. To verify the effects of UPR inducing treatments (except TN) on LLO synthesis, controls (not shown) were performed with cells labeled with 40 μCi/ml [2-3H]mannose, in which case a 20-min incubation with medium containing 0.5 mm glucose was used. [3H]LLOs were extracted with chloroform/methanol/water (10:10:3), and [3H]oligosaccharides were released from dolichol-P-P and analyzed by HPLC as described (6Doerrler W.T. Lehrman M.A. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 13050-13055Google Scholar).Table IIEffects of DTT- and TN-induced ER stress on 5′-AMP-dependent and -independent glycogen phosphorylase activities in primary dermal fibroblastsFibroblast cultures:−AMP+AMPControlDTTTNControlDTTTNunits/min/mg prot. ± S.E.% control% controlunits/min/mg prot. ± S.E.% control% controlAdultCRL-19040.080 ± 0.005188 ± 27204 ± 230.299 ± 0.015110 ± 9100 ± 3(n = 8)(n = 6)(n = 4)bTN-treated CRL-1904 cultures had a set of controls (n = 6) different than those for DTT, with average activities of 0.082 ± 0.006 (−AMP) and 0.278 ± 0.006 (+AMP).(n = 8)(n = 6)(n = 4)bTN-treated CRL-1904 cultures had a set of controls (n = 6) different than those for DTT, with average activities of 0.082 ± 0.006 (−AMP) and 0.278 ± 0.006 (+AMP).CRL-18920.075 ± 0.003140 ± 9188 ± 200.200 ± 0.011113 ± 7137 ± 9(n = 7)(n = 5)(n = 5)(n = 7)(n = 5)(n = 5)CRL-19870.068 ± 0.0071391700.192 ± 0.006122135(n = 2)(n = 1)(n = 1)(n = 2)(n = 1)(n = 1)F-120.066 ± 0.008134 ± 6NDcNot determined.0.170 ± 0.01390 ± 4ND(n = 2)(n = 2)(n = 2)(n = 2)F21–30.068 ± 0.003152 ± 8ND0.178 ± 0.002109 ± 3ND(n = 2)(n = 2)(n = 2)(n = 2)PediatricaCRL-7514: 4-year-old Caucasian male, neuroblastoma. CRL-2114: 2-year-old Black male, no clinical abnormalities recorded. CRL-1513: 4-year-old male, ethnicity unrecorded, multiple congenital defects (LLO profiles were normal and responsive to ER stress (4), inconsistent with CDG-I). CRL-1474: 7-year-old male, ethnicity unrecorded, glioma.CRL-75140.027 ± 0.0002194 ± 18171 ± 160.085 ± 0.001102 ± 495 ± 1(n = 2)(n = 2)(n = 2)(n = 2)(n = 2)(n = 2)CRL-21140.026 ± 0.001205 ± 9180 ± 710.068 ± 006101 ± 686 ± 17(n = 2)(n = 2)(n = 2)(n = 2)(n = 2)(n = 2)CRL-15130.037 ± 0.002161 ± 51770.106 ± 0.00497 ± 1294(n = 2)(n = 2)(n = 1)(n = 2)(n = 2)(n = 1)CRL-14740.044 ± 0.00182 ± 31020.120 ± 0.00473 ± 667(n = 2)(n = 2)(n = 1)(n = 2)(n = 2)(n = 1)Glycogen phosphorylase was assayed without or with 5 mm5′-AMP in cytoplasmic extracts from cells treated in the absence (control) or presence of 2 mm DTT for 15 min, or 5 μg/ml TN for 60 min, and normalized to protein content, as described under “Experimental Procedures.” Cultures with CRL designations were from the American Type Culture Collection. F-12 was a gift of Dr. H. Freeze, Burnham Institute, and F21–3 was obtained from National Psoriasis Foundation Tissue Bank. Adult donors were clinically normal. Pediatric donors were normal or had clinical abnormalities not expected to affect the parameters measured here. For reasons that are unclear, the average GP activities among the 5 adult cultures (−AMP, 0.072; +AMP; 0.21) were higher than those for four pediatric cultures (−AMP, 0.034; +AMP, 0.095). GP activity in only one of 9 cultures, pediatric CRL-1474, did not respond to ER stress. Since this culture also had the highest GP activity among the four pediatric cultures, there is a possibility of constitutive activation of GP.a CRL-7514: 4-year-old Caucasian male, neuroblastoma. CRL-2114: 2-year-old Black male, no clinical abnormalities recorded. CRL-1513: 4-year-old male, ethnicity unrecorded, multiple congenital defects (LLO profiles were normal and responsive to ER stress (4Shang J. Koerner C. Freeze H.H. Lehrman M.A. Glycobiology. 2002; 12: 307-317Google Scholar), inconsistent with CDG-I). CRL-1474: 7-year-old male, ethnicity unrecorded, glioma.b TN-treated CRL-1904 cultures had a set of controls (n = 6) different than those for DTT, with average activities of 0.082 ± 0.006 (−AMP) and 0.278 ± 0.006 (+AMP).c Not in a Table stress not the activities of key enzymes and factors involved in hexose phosphate or factor of ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± are described under “Experimental Procedures.” are of protein in and activities were all measured in and are as of is measured as of activity cells is as the of the of the of stress was in a phosphorylase was assayed without or with 5 mm5′-AMP in cytoplasmic extracts from cells treated in the absence (control) or presence of 2 mm DTT for 15 min, or 5 μg/ml TN for 60 min, and normalized to protein content, as described under “Experimental Procedures.” Cultures with CRL designations were from the American Type Culture Collection. F-12 was a gift of Dr. H. Freeze, Burnham Institute, and F21–3 was obtained from National Psoriasis Foundation Tissue Bank. Adult donors were clinically normal. Pediatric donors were normal or had clinical abnormalities not expected to affect the parameters measured here. For reasons that are unclear, the average GP activities among the 5 adult cultures (−AMP, 0.072; +AMP; 0.21) were higher than those for four pediatric cultures (−AMP, 0.034; +AMP, 0.095). GP activity in only one of 9 cultures, pediatric CRL-1474, did not respond to ER stress. Since this culture also had the highest GP activity among the four pediatric cultures, there is a possibility of constitutive activation of are described under “Experimental Procedures.” are of protein in and activities were all measured in and are as of is measured as of activity cells is as the of the of the of stress was Cell were treated with by to the as described J. Biol. Chem. Scholar, S. M.A. J. J. Lehrman M.A. Biol. Cell. 2001; 12: Scholar), allowing of cytoplasmic components with or with on for min, was by the with 2 of transport mm mm and mm DTT as Ref. J. Biol. Chem. Scholar) to were 15 min the were on for 5 The was and used for of was measured with a with as a of extracts this with extracts with that as a of GP (not The various stress treatments described in this study did not the of protein in cytoplasmic were the incubation for all enzymes in of cytoplasmic were assayed in of containing mm mm and 5 mm were performed in the presence of of and mm and was for the of to as described J. Scholar). for the incubation and other are for In all with the enzyme were data were normalized to protein were for 15 min with mm and mm were for 15 min with mm were for 2 h with mm and were for 2 h with mm mm glucose and of were for 15 min with and of of was with of containing mm or mm mm mm mm mm of of and of and for 15 min The of was with K. J. Biol. Chem. Scholar). was measured by activation of as described K. J. Biol. Chem. Scholar). and in extracts from control and cells were were obtained by as were on and with of was and cells were to a and for 20 The was for 5 were on and for 20 min in a The were and to In was activated by extracts from control by (see were assayed for GP activity J. Scholar). was of containing 20 mm phosphate 2 mm 2 μg/ml and glucose 5 mm was The was by of glycogen GP activity was a of 5 h and for were this were for and of The was dependent upon the presence of and (not for GP activity in the presence of the activity without of activity obtained in the absence of extracts containing hexose (see were used. Since hexose can be by key were (not shown) with mm mm and of 2 μg/ml was and was measured after 15 performed in the absence of were Cell were extracted by The was by under in and to a of with 20 of which all hexose were with 15 of acid Scholar) and under of a was than (not However, hexose were highly to and under more than of Glc-1-P was as Thus, glucose in the acid and hexose were with and with a Lehrman M.A. 2002; 12: Scholar) of a with mm and a with mm The was other of the were to those described for were with a as described Lehrman M.A. 2002; 12: Scholar). was extracted from in on and with by with of acid by D. K. Of Scholar). of by were used for of glucose with or without of was by of with of and 2 of by 40 for 2 The incubation was by of with a of and for 15 was assayed by to of the with of containing mm mm mm and 5 μg/ml incubation for 5 min, was was to a of 5 min was from which the was to the in of obtained without and with glucose the of glucose was with such as and is regulation of or in dermal of regulatory in hexose metabolism with the to modulate LLO were to whether be regulated by the UPR ER stress to LLO extension were These did not cause cytoplasmic stress, a of hexose and A. DTT was it within 20 min of to and its effects on LLO extension were to ER stress response rather than a of a regulatory enzyme (4Shang J. Koerner C. Freeze H.H. Lehrman M.A. Glycobiology. 2002; 12: 307-317Google Scholar). However, for the study were cells were continuously in medium with 5 mm In a 20-min in 0.5 mm glucose medium was to a of TN not be used in studies it LLO TN was used in the present study UPR be activated by extracts were by of the with to of from J. Biol. Chem. Scholar). Thus, were to No were for key enzymes and were no stress effects on enzymes that a key in to mannosyl No were in the enzymes or cytoplasmic of as that of and and hexose from to with the of evidence for enhanced glucose and from culture medium (6Doerrler W.T. Lehrman M.A. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 13050-13055Google Scholar), no were for of which of hexose as was also and (6Doerrler W.T. Lehrman M.A. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 13050-13055Google Scholar) it is that ER stress not cause in activities involved in hexose in GP activity was in fibroblasts in its more and this enzyme in fibroblasts is by extension from such as and it is that phosphorylation the to the more J. Scholar). which to the dependent activity not the AMP-independent activity cells were treated with DTT, TN or AZC (not shown) to cause ER stress (4Shang J. Koerner C. Freeze H.H. Lehrman M.A. Glycobiology. 2002; 12: 307-317Google Scholar), AMP-independent GP activity in extracts activity was Activation of GP within 20 min of DTT of DTT to or its did not affect GP activity (not Thus, by DTT was not to a of GP or a of GP, as expected the cytoplasmic in which GP is highly In to the culture used in the experiments in the ER stress with DTT or TN not activities in other adult and pediatric dermal cultures The of GP by ER stress did not the evidence that this was fibroblasts on of glucose In the presence of GP glycogen of glycogen were with DTT ± = and TN ± = For DTT, the after 15 min of Since cellular glycogen may be by its synthesis, the effect of TN may be to the that it more Thus, the be more by glycogen These of were more than to for effects on hexose and LLOs of hexose from ER of of ER Glc-1-P mm μg/ml mm DTT mm DTT mm DTT μg/ml TN μg/ml hexose in Glc3Man9GlcNAc2-P-P-dolichol are upon of Glc-1-P were from the of glycogen as in the hexose to ER stress were by and enzyme as described under “Experimental with from unstressed cells The of glucose in Glc3Man9GlcNAc2-P-P-dolichol by in dermal fibroblasts in 5 mm glucose Scholar) was used to the of hexose that be for extension of lipid-linked to ER stress. in a are upon of Glc-1-P were from the of glycogen as in the hexose to ER stress were by and enzyme as described under “Experimental with from unstressed cells The of glucose in Glc3Man9GlcNAc2-P-P-dolichol by in dermal fibroblasts in 5 mm glucose Scholar) was used to the of hexose that be for extension of lipid-linked to ER stress. carbohydrate of Glc-1-P of control after 15 min of DTT and after min not The effect Glc-1-P can be with by Glc-1-P can be to by Thus, it was that a of Glc-1-P to other with DTT, TN, and ER cytoplasmic CSN, a UPR (4Shang J. Koerner C. Freeze H.H. Lehrman M.A. Glycobiology. 2002; 12: 307-317Google Scholar), the response. The effect of DTT was within 5 min of to cultures and was after 15 as as mm were These were in with the that LLO extension was by mm DTT and within 20 min of to cultures (4Shang J. Koerner C. Freeze H.H. Lehrman M.A. Glycobiology. 2002; 12: 307-317Google Scholar). DTT also in of measured by This was than that measured by enzyme the were in the of to cells This suggests that in the may to the in the for Glc-6-P. that ER stress activates GP, associated with and generation of Glc-1-P and Glc-6-P. in Table ER stress of than to synthesis of Glc3Man9GlcNAc2-P-P-dolichol in cells as measured by Lehrman M.A. 2002; 12: Scholar). the of the not used for LLO extension is for In all is to AMP-independent by phosphorylation J. Scholar). Thus, a of phosphatase inhibitors was the of extracts to the of ER stress activation of The were inhibitors had no effect on AMP-independent GP activity in extracts from the activity from unstressed cells to from Thus, the of phosphatase inhibitors had the effect on GP activity as cells with UPR were not the phosphorylation occurs not only in the also in the and/or under the inhibitor without The of data for regulation by phosphorylation are under the and in for of LLO extension by UPR regulation of of LLO such as by glucose in ER stress. in this study ER stress activates glycogen phosphorylase (GP). in turn, from in of for extension of LLO intermediates to In this we that the UPR may of GP to of regulation by data of a phosphatase inhibitor that GP from activation of a kinase that for GP and/or phosphorylation of a of This study identified AMP-independent glycogen phosphorylase as a for the ER extension of LLO precursors and of Glc3Man9GlcNAc2-P-P-dolichol of for had 4Shang J. Koerner C. Freeze H.H. Lehrman M.A. Glycobiology. 2002; 12: 307-317Google and 6Doerrler W.T. Lehrman M.A. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 13050-13055Google the other enzymes and factors were by ER stress. with phosphatase inhibitors were with activation of AMP-independent GP activity by a it is not whether ER stress controls one of the identified of GP such as phosphorylase kinase or protein phosphatase or a of no in GP activity was in in the presence of suggesting that the of enzyme was it that GP was also activated by or another cytoplasmic that ER stress GP activity by no more than a factor of and only of glycogen were However, activation of GP was as in Table the of from glycogen is the to for LLO GP is is and Glc-1-P and are by and of UPR that are highly with those that LLO extension (4Shang J. Koerner C. Freeze H.H. Lehrman M.A. Glycobiology. 2002; 12: 307-317Google Scholar). (6Doerrler W.T. Lehrman M.A. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 13050-13055Google Scholar) and Freeze H. Biol. Chem. 2001; Scholar) studies that is of hexose for LLO in glycogen appears to as a accumulation of LLO intermediates to glucose J. Scholar). that GP is the UPR for extension of LLOs that specific of GP activation. The effects of GP activation by ER stress on the pathway from glycogen to which is the for to be However, that this is also In cells that accumulate more than Glc3Man9GlcNAc2-P-P-dolichol to glucose ER stress the of in cells was used to mannosyl residues (6Doerrler W.T. Lehrman M.A. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 13050-13055Google Scholar). the stress treatments the of was used to residues not The requires of to and Since is also from Glc-1-P from be ER stress and the from In with this ER stress enhanced the of LLOs in of in which of LLOs is to a that the activity of (4Shang J. Koerner C. Freeze H.H. Lehrman M.A. Glycobiology. 2002; 12: 307-317Google Scholar). Thus, of and compensate for the The rapid activation of GP, with the evidence for a of suggests regulation by post-translational rather than the UPR signaling that this is most of eIF2α phosphorylation by the ER stress kinase In fibroblasts, GP activation and eIF2α phosphorylation (4Shang J. Koerner C. Freeze H.H. Lehrman M.A. Glycobiology. 2002; 12: 307-317Google Scholar) occur within min of application of ER stress. be to whether GP can be activated in a such as PERK fibroblasts H.P. Zhang Y. A. H. Ron D. Cell. 2000; Scholar). transcriptional post-translational can be identified as promoting of eIF2α H. H.P. Ron D. J. Cell Biol. 2001; Scholar), a may be for ER stress a phosphatase inhibitor the UPR may control by and and the we on the of LLO extension in the UPR (4Shang J. Koerner C. Freeze H.H. Lehrman M.A. Glycobiology. 2002; 12: 307-317Google Scholar), the UPR appears to in The which within of the generation of ER stress, may be for ER damage This is by that can the causes of ER stress, such as by increasing the of for LLO synthesis and and by the of protein entering the However, occur hours the by of the ER in a manner gene in no found that is also for of this and in several of the and for in glycogen phosphorylase

References

15